1. The sale was made pursuant to Reporting Person's Rule 10b5-1 Trading Plan.

2. Represents the actual selling price for all 2,335 shares.

3. 7,007 shares shall vest upon the Company achieving total revenue in any of the 2013, 2014, or 2015 fiscal years equal to or greater than $12 billion; 2,654 shares shall vest upon the Company achieving three-year Total Stockholder Return (TSR) as determined by ISS calculations that is greater than the median TSR achieved by the Company's ISS peer group for the three-year period ending December 31, 2016; continued

4. 2,654 shares shall vest on March 1, 2015 contingent upon the Company achieving a one-year TSR as determined by ISS calculations for fiscal year 2014 that is greater than the average TSR achieved by Centene Corporation and WellCare Group for their fiscal year ending December 31, 2014; 6,635 shares shall vest upon the Company achieving a three-year EBITDA margin percentage for the three-year period ending December 31, 2016 equal to or greater than 4.0%; continued

5. 6,635 shares vest upon the Company achieving a cumulative earnings per share of at least $8.50 for the three year period ending December 31, 2016; and 18,115 shares vest on March 1, 2015; 8,740 shares vest on March 1, 2016; and 2,654 shares vest on March 1, 2017. The remainder of the shares are vested.

Jeff D. Barlow, by power of attorney for Joseph W. White.

04/02/2014

** Signature of Reporting Person

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person,
see
Instruction
4
(b)(v).